• 1
    Quarto M, Germinario C, Fontana A, Barbuti S. HIV transmission through kidney transplantation from a living donor. N Engl J Med 1989; 320: 1754.
  • 2
    Samuel D, Castaing D, Adam R, Saliba F, Chamaret S, Misset JL, et al. Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft. Lancet 1988; 1: 12211222.
  • 3
    Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726732.
  • 4
    Centers for Disease Control. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody—North Carolina. MMWR Morb Mortal Wkly Rep 1987; 36: 306308.
  • 5
    Prompt CA, Reiss MM, Grillo FM, Kopstein J, Kraemer E, Manfro R, et al. Transmission of AIDS virus at renal transplantation. Lancet 1985; 2: 672.
  • 6
    Schwarz A, Hoffmann F, L'Age-Stehr J, Tegzess AM, Offermann G. Human immunodeficiency virus transmission by organ donation. Transplantation 1987; 44: 2124.
  • 7
    L'Age-Stehr J, Schwarz A, Offermann G, Langmaack H, Bennhold I, Niedrig M, Koch MA. HTLV-III infection in kidney transplant recipients. Lancet 1985; 2: 13611362.
  • 8
    Kumar P, Pearson JE, Martin DH, Leech SH, Buisseret PD, Bezbak HC, et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106: 244245.
  • 9
    Centers for Disease Control. Testing donors of organs, tissues, and semen for antibody to human T-lymphotrophic virus type III/lymphoadenopathy-associated virus. MMWR Morb Mortal Wkly Rep 1985; 34: 294.
  • 10
    The Organ Procurement and Transplantation Network. Available at: Accessed March 2008.
  • 11
    Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 9197.
  • 12
    Horsburgh CR Jr, Ou C-Y, Jason J, Holmberg SD, Longini IM Jr, Schable C, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989; 16: 637640.
  • 13
    Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254264.
  • 14
    Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 18711879.
  • 15
    Centers for Disease Control. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR Recomm Rep 1994; 43: 117.
  • 16
    Pereira BJG, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454460.
  • 17
    Tugwell BD, Patel PR, Williams IT, Hedberg K, Chai F, Nainan OV, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005; 143: 648654.
  • 18
    Centers for Disease Control. Hepatitis C virus transmission from an antibody-negative organ and tissue donor—United States, 2000-2002. MMWR Morb Mortal Wkly Rep 2003; 52: 273276.
  • 19
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 16851690.
  • 20
    Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333: 17211725.
  • 21
    Dodd RY, Notari IV, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975979.
  • 22
    Phelps R, Robbins K, Liberti T, Machuca A, Leparc G, Chamberland M, et al. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 2004; 44: 929933.
  • 23
    Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet 2000; 355: 4142.
  • 24
    Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003; 43: 721729.
  • 25
    Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C, and human immunodeficiency virus in the United States. Vox Sang 2004; 86: 2840.
  • 26
    Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Alfonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47: 407417.
  • 27
    Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing Database. Transplantation 2008; 85: 359368.
  • 28
    Schreibmann I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007; 84: 697705.
  • 29
    Samuel D, Weber R, Stock P, Duclos-Vallee JC, Terrault N. Are HIV-infected patients candidates for liver transplantation. J Hepatol 2008; 48: 697707.
  • 30
    Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355365.